Our priority:
Your health
Fidia farmaceutici S.p.A. operates in numerous therapeutic areas, providing specific treatments for commonly occurring pathologies with serious social repercussions.
Joint care
The field of joint disorders is one of the areas in which Fidia has been active longest: over 50 years of research into hyaluronic acid have placed the company at the forefront in research, technological development, production and economic turnover, not only in Italy but worldwide.
Since normal joint movement involves maintenance of healthy cartilage and tendons, Fidia's commitment has been to identify innovative and integrated solutions in the prophylaxis and treatment of cartilage and tendon pathologies, with different approaches: peri-articular therapy (both oral and topical) and intra-articular therapy (injections of hyaluronic acid), thus offering an exciting array of therapeutic option to the treatment of osteoarthritis and cartilage damage.
Since normal joint movement involves maintenance of healthy cartilage and tendons, Fidia's commitment has been to identify innovative and integrated solutions in the prophylaxis and treatment of cartilage and tendon pathologies, with different approaches: peri-articular therapy (both oral and topical) and intra-articular therapy (injections of hyaluronic acid), thus offering an exciting array of therapeutic option to the treatment of osteoarthritis and cartilage damage.
Wound Care
Hyaluronic acid treatments are well known and have long been widely used in tissue repair to treat general wounds, ulcers, bedsores, and for the topical treatment of burns.
Fidia has developed a unique and exclusive project, based on high-tech, hyaluronan-based bioactive treatments to manage acute and chronic lesions, a disabling pathology that is becoming increasingly common, as life expectancy lengthens and chronic, disabling conditions increase as a result.
Fidia has developed a unique and exclusive project, based on high-tech, hyaluronan-based bioactive treatments to manage acute and chronic lesions, a disabling pathology that is becoming increasingly common, as life expectancy lengthens and chronic, disabling conditions increase as a result.
